Shane Duncan Archives | Cannabiz

GSK agreement ‘validates’ Satipharm strategy as Cann Group pins hopes on positive clinical trial

by Steve Jones April 7, 2022April 8, 2022

The interest from pharmaceutical giant GlaxoSmithKline in marketing and selling Satipharm CBD products has validated Cann […]

Cann Group not ruling out further capital raise

by Steve Jones February 23, 2022February 24, 2022

Over-the-counter race hots up as Cann Group prepares to recruit patients for sleep disturbance trial

by Steve Jones February 16, 2022February 16, 2022

A year of frustration but Cann Group vows to deliver for shareholders and consumers

by Steve Jones August 12, 2021August 17, 2021

Cann Group ships delayed order of 20,000 bottles to German partner iuvo

by Steve Jones May 6, 2021May 6, 2021

TGA boss tells industry: ‘future dosing limits are in your hands’

by Martin Lane March 16, 2021March 16, 2021

Cannatrek releases first home-grown flower as firms react to shortage

by Steve Jones March 11, 2021March 15, 2021

Cann Group COO: ‘we need to put our big boy pants on and adopt a pharmaceutical mindset’

by Steve Jones February 25, 2021February 25, 2021

Cann Group eyes S3 product and the end of ‘unsophisticated’ formulations

by Steve Jones February 18, 2021February 25, 2021

Cann Group ships first batch of medicinal cannabis oil to the UK

by Martin Lane December 23, 2020December 23, 2020